KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Novartis Ag (NVS) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to -$11.6 billion.

  • Novartis Ag's Enterprise Value rose 1387.38% to -$11.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$11.6 billion, marking a year-over-year increase of 1387.38%. This contributed to the annual value of -$11.6 billion for FY2025, which is 1387.38% up from last year.
  • As of Q4 2025, Novartis Ag's Enterprise Value stood at -$11.6 billion, which was up 1387.38% from -$9.6 billion recorded in Q3 2025.
  • In the past 5 years, Novartis Ag's Enterprise Value registered a high of -$5.0 billion during Q1 2022, and its lowest value of -$6000.3 billion during Q1 2021.
  • Its 5-year average for Enterprise Value is -$312.6 billion, with a median of -$11.9 billion in 2023.
  • Its Enterprise Value has fluctuated over the past 5 years, first plummeted by 115158445.3% in 2021, then surged by 9991.61% in 2022.
  • Quarter analysis of 5 years shows Novartis Ag's Enterprise Value stood at -$28.3 billion in 2021, then skyrocketed by 33.18% to -$18.9 billion in 2022, then increased by 23.78% to -$14.4 billion in 2023, then increased by 6.73% to -$13.5 billion in 2024, then increased by 13.87% to -$11.6 billion in 2025.
  • Its Enterprise Value stands at -$11.6 billion for Q4 2025, versus -$9.6 billion for Q3 2025 and -$7.0 billion for Q2 2025.